[Efficacy of indinol in antirecurrence therapy of juvenile respiratory papillomatosis].

Autor: Soldatskiĭ IuL, Kiselev VI, Onufrieva EK, Steklov AM, Shchepin NV, Strygina IuV, Gasparian SF, Pogosova IE
Jazyk: ruština
Zdroj: Vestnik otorinolaringologii [Vestn Otorinolaringol] 2006 (1), pp. 46-8.
Abstrakt: The study of indinol efficacy in antirecurrence therapy of respiratory papillomatosis was performed in 46 children aged 2-14 years. The treatment lasted at least 12 weeks. Duration of a recurrence-free period before and after indinol administration was analysed. The response was observed in 30 (65.2%) patients. In 5 (10.9%) patients the remission continued from 2 to 3 years 10 months. In 25 (54.3%) patients recurrence-free period increased 1,5-6-fold. Side effects were not registered. Simple in use, cheap, well tolerated, usable with other treatments, indinol is recommended as a method of choice in antirecurrence treatment of recurrent respiratory papillomatosis.
Databáze: MEDLINE